Concepedia

Publication | Open Access

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa

DOIFull Paper Access

191

Citations

16

References

2019

Year

Jason M. Pogue, Keith S. Kaye, Michael P. Veve, Twisha S Patel, Anthony T. Gerlach, Susan L. Davis, Laura Puzniak, T. M. File, Shannon Olson, Sorabh Dhar,
Clinical Infectious Diseases

Abstract

These data support the preferential use of ceftolozane/tazobactam over polymyxins or aminoglycosides for drug-resistant P. aeruginosa infections.

References

YearCitations

Page 1